• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Model Number B1070-040
Device Problems Material Rupture (1546); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/23/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat 2 lesions, one in the arteriovenous (av) graft and one at the venous anastomosis due to high grade stenosis.The venous anastamosis of the av graft would not open completely and an angiogram showed residual stenosis, therefore an absolute pro stent was deployed.Additional angioplasty was attempted as standard practice using a 7.0x40mm armada 35 balloon but the balloon ruptured at 20atm on the third inflation.The armada 35 was replaced with a non-abbott 7mmx4cm high pressure balloon to successfully completely the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Product performance engineering reviewed the complaint information and analysis of the returned unit.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other similar complaints.It should be noted that the instructions for use, pta, armada 35 / armada 35 ll, global, ce, costa rica, section 1 description states: the balloon is inflated using the side leg port, at which the balloon expands to a known diameter at specific pressure.The working pressure range for the balloon is between the nominal pressure and the rated burst pressure.All balloons distend to sizes above the nominal diameter at pressures greater than the nominal pressure.Additionally, in section iv, warnings/precautions it states: inflation in excess of the rated burst pressure may cause the balloon to rupture.In this case the reported ifu violation likely did cause or contribute to the reported material rupture.Based on the information provided, the balloon rupture was due the anatomical conditions related to the circumstances of the procedure.In this case, it is likely that the balloon pressurized as many as three times above the recommended rbp of 15 atm in order to overcome the anatomical conditions, led to the balloon rupture.The armada 35 balloon is a compliant (elastomeric) balloon which expands to a known diameter at specific pressure.The working pressure range for the balloon is between the nominal pressure and the rated burst pressure.Compliant balloons distend to sizes above the nominal diameter at pressures greater than the nominal pressure.Noncompliant (high-pressure) balloons are typically used for applications in which the balloon needs to expand to a specific diameter and exert high pressure to open a blockage or dilate the vasculature.Being that the armada 35 is a compliant balloon, they are inflated by volume, rather than pressure.Able to stretch 100% to 800%, they are often used in applications that require the balloon to fully conform to or occlude the anatomy.Based on the reported case information, user technique in conjunction with challenging lesion characteristics likely contributed to the reported difficulties, as the armada balloon likely conformed to the blockage as designed, leading the physician to inflate above rbp.There is no indication to suggest a product quality issue with respect to manufacture, design, or manufacture, or labeling of the armada 35 device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 35 PTA CATHETER
Type of Device
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10845216
MDR Text Key219569948
Report Number2024168-2020-09566
Device Sequence Number1
Product Code LIT
UDI-Device Identifier08717648154782
UDI-Public08717648154782
Combination Product (y/n)N
PMA/PMN Number
K111899
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model NumberB1070-040
Device Catalogue NumberB1070-040
Device Lot Number00423G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/24/2020
Date Manufacturer Received12/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ABSOLUTE PRO
Patient Age50 YR
Patient Weight93
-
-